Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07643987 · ClinicalTrials.gov registry record
Diagnosis of Gestational Diabetes Based on a 50-gram Glucose Challenge
A clinical trial, sponsored by Methodist Health System.
- Completed
- Registry status
- 351
- Enrollment target
NCT07643987: Completed study, sponsored by Methodist Health System.
NCT07643987 is a clinical trial that has completed, run by Methodist Health System. The registered enrollment target is 351 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07643987 has completed, sponsored by Methodist Health System.
- COMPLETED
- Registry status
- 351 participants
- Enrollment target
Study Summary
The aim of this study is to determine a 1-hour glucose tolerance test (GTT) value at which the diagnosis of gestational diabetes can be made without undergoing a 3-hour test.
Primary Outcome
The primary outcome will be the 50-gram glucose results for patients that were diagnosed with gestational diabetes by a 100-gram glucose challenge.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 351 participants |
| Start Date | 2023-05-09 |
| Est. Completion | 2024-03-29 |
What the finished NCT07643987 record still lists
NCT07643987 is an observational study that tracks outcomes without assigning an intervention. The registered 351 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT07643987 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07643987 about?
NCT07643987 is a clinical study titled "Diagnosis of Gestational Diabetes Based on a 50-gram Glucose Challenge". The aim of this study is to determine a 1-hour glucose tolerance test (GTT) value at which the diagnosis of gestational diabetes can be made without undergoing a 3-hour test.
What is the current status of trial NCT07643987?
This trial is currently completed. The enrollment target is 351 participants. The study started on 2023-05-09. Estimated completion is 2024-03-29.
Who is sponsoring clinical trial NCT07643987?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06241456 · 351 participants · Phase 1
FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors
- NCT06576726 · 351 participants
Sensorimotor and Psychosocial Trajectories in Adolescents With Tic Disorder
- NCT07043400 · 351 participants · Phase 3
A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
- NCT07261423 · 351 participants · NA
Pollution Intervention to Impact Kids Asthma Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI